Literature DB >> 22672092

Update on the pharmacologic treatment of hypertension in pediatrics.

Douglas L Blowey1.   

Abstract

J Clin Hypertens (Greenwich). 2012; 14:383-387. ©2012 Wiley Periodicals, Inc. The past decade of investigation into the pharmacologic treatment of hypertension in children has been rewarding. The studies have shown that blood pressure medications effectively reduce blood pressure in children with hypertension and that these agents are generally well tolerated with few treatment-related adverse effects. While we have advanced our capacity to make rational therapeutic decisions, future efforts must be directed towards comparing the effectiveness of the different classes of antihypertensive agents and studies evaluating the impact of antihypertensive agents on outcome.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22672092      PMCID: PMC8108808          DOI: 10.1111/j.1751-7176.2012.00659.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  29 in total

Review 1.  Left ventricular hypertrophy as a predictor of cardiovascular risk.

Authors:  Philippe Gosse
Journal:  J Hypertens Suppl       Date:  2005-04

Review 2.  Effects of antihypertensive drugs on blood pressure and proteinuria in childhood.

Authors:  Giacomo D Simonetti; Mattia Rizzi; Rebecca Donadini; Mario G Bianchetti
Journal:  J Hypertens       Date:  2007-12       Impact factor: 4.844

3.  Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.

Authors:  Ji-Guang Wang; Jan A Staessen; Yan Li; Luc M Van Bortel; Tim Nawrot; Robert Fagard; Franz H Messerli; Michel Safar
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

4.  Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience.

Authors:  Donald L Batisky; Jonathan M Sorof; Jennifer Sugg; Michaelene Llewellyn; Michael Klibaner; James W Hainer; Ronald J Portman; Bonita Falkner
Journal:  J Pediatr       Date:  2007-02       Impact factor: 4.406

5.  Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class.

Authors:  Michael J Bloch; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

6.  Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.

Authors:  Demetrius Ellis; Michael L Moritz; Abhay Vats; Janine E Janosky
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

7.  Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.

Authors:  Elke Wühl; Otto Mehls; Franz Schaefer
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

8.  Carotid ultrasonography for detection of vascular abnormalities in hypertensive children.

Authors:  Jonathan M Sorof; Andrei V Alexandrov; Zsolt Garami; Jennifer L Turner; Robert E Grafe; Dejian Lai; Ronald J Portman
Journal:  Pediatr Nephrol       Date:  2003-07-18       Impact factor: 3.714

9.  Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension.

Authors:  Thomas Wells; Jeffrey Blumer; Kevin E C Meyers; Jose P R Neto; Rejane Meneses; Mieczysław Litwin; Johan Vande Walle; Susan Solar-Yohay; Victor Shi; Guangyang Han
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

10.  Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.

Authors:  Howard Trachtman; James W Hainer; Jennifer Sugg; Renli Teng; Jonathan M Sorof; Jerilynn Radcliffe
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-10       Impact factor: 3.738

View more
  6 in total

Review 1.  A systems-based approach to managing blood pressure in children following kidney transplantation.

Authors:  David K Hooper; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

Review 2.  Rational use of antihypertensive medications in children.

Authors:  Michael A Ferguson; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

Review 3.  What is the optimal first-line agent in children requiring antihypertensive medication?

Authors:  Donald L Batisky
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 4.  Hypertension in the teenager.

Authors:  Elizabeth I Anyaegbu; Vikas R Dharnidharka
Journal:  Pediatr Clin North Am       Date:  2013-10-30       Impact factor: 3.278

5.  Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults.

Authors:  Nicholas J A Webb; Thomas Wells; Max Tsai; Zhen Zhao; Attila Juhasz; Caroline Dudkowski
Journal:  Eur J Clin Pharmacol       Date:  2016-01-04       Impact factor: 2.953

6.  7th Brazilian Guideline of Arterial Hypertension: Chapter 10 - Hypertension in Children and Adolescents

Authors:  M V B Malachias; V Koch; Colombo Colombo; Silva Silva; I C B Guimarães; P K Nogueira
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.